Metraipolis › archive › dc_f8316f66e69a
HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal disease — Europe PMC PMID:41938756
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41938756
- DOI
- 10.1093/noajnl/vdag048
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T03:32:47.167Z
- SHA-256 of the archived text
425d12443b01ac4e8cedfde4f5876925c062b1ec26fccfc091a80051d4debbb4- Stable URL of this page
https://metraipolis.com/documento/dc_f8316f66e69a
How to cite
HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal disease — Europe PMC PMID:41938756 — Europe PMC (en), https://europepmc.org/article/MED/41938756 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f8316f66e69a (Metraipolis archive dc_f8316f66e69a, sha256 425d12443b01ac4e8cedfde4f5876925c062b1ec26fccfc091a80051d4debbb4)
BibTeX
@misc{dcf8316f66e69a,
title = {HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal disease — Europe PMC PMID:41938756},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41938756},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f8316f66e69a; sha256 425d12443b01ac4e8cedfde4f5876925c062b1ec26fccfc091a80051d4debbb4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41938756. Agents can read the archived copy with the MCP tool read_document.